Browsing by Author Pérez Galán, Patricia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
19-Dec-2015CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaMontraveta, Arnau; Lee-Vergés, Eriong; Roldán, Jocabed; Jiménez, Laura; Cabezas, Sandra; Clot, Guillem; Pinyol, Magda; Xargay i Torrent, Sílvia; Rosich, Laia; Arimany Nardi, Cristina; Aymerich Gregorio, Marta; Villamor i Casas, Neus; López Guillermo, Armando; Pérez Galán, Patricia; Roué, Gaël; Pastor Anglada, Marçal; Campo Güerri, Elias; López-Guerra, Mónica; Colomer Pujol, Dolors
11-Jul-2019Daratumumab displays in vitro and in vivo anti-tumor activity in models of B cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimensVidal Crespo, Anna; Matas Céspedes, Alba; Rodríguez, Vanina; Rossi, Cédric; Valero, Juan G.; Serrat, Neus; Sanjuan Pla, Alejandra; Menéndez Buján, Pablo; Roué, Gaël; López Guillermo, Armando; Giné Soca, Eva; Campo Güerri, Elias; Colomer Pujol, Dolors; Bezombes, Christine; Lammerts van Bueren, J.; Chiu, Christopher; Doshi, Parul; Pérez Galán, Patricia
6-Dec-2018Development of a novel anti-CD19 chimeric antigen receptor: A paradigm for an affordable CAR T cell production at academic institutionsCastella, Maria; Boronat, Anna; Martín Ibáñez, Raquel; Rodríguez, Vanina; Suñé, Guillermo; Caballero, Miguel; Marzal, Berta; Pérez-Amill, Lorena; Martín-Antonio, Beatriz; Castaño, Julio; Bueno, Clara; Balagué, Olga; González-Navarro, Europa Azucena; Serra Pagès, Carles; Engel Rocamora, Pablo; Vilella, Ramon; Benítez-Ribas, Daniel; Ortiz-Maldonado, Valentín; Cid Vidal, Joan; Tabera, Jaime; Canals i Coll, Josep M.; Lozano, Miquel; Baumann, Tycho; Vilarrodona, Anna; Trias, Esteve; Campo Güerri, Elias; Menéndez Buján, Pablo; Urbano Ispizua, Álvaro; Yagüe, Jordi; Pérez Galán, Patricia; Rives, Susana; Delgado, Julio (Delgado González); Juan, Manel
Feb-2019Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomasRoisman, Alejandro; Castellano, Giancarlo; Navarro, Alba; González Farré, Blanca; Pérez Galán, Patricia; Esteve Codina, Anna; Dabad, Marc; Heath, Simon C.; Gut, Marta; Bosio, Mattia; Bellot, Pau; Salembier, Philippe; Oliveras, Albert; Slavutsky, Irma; Magnano, Laura; Horn, Heike; Rosenwald, Andreas; Ott, German; Aymerich Gregorio, Marta; López Guillermo, Armando; Jares Gerboles, Pedro; Martín-Subero, José Ignacio; Campo Güerri, Elias; Hernández, Luis
25-Jul-2014Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphomaRosich, Laia; Montraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Roldán, Jocabed; Aymerich Gregorio, Marta; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Campo Güerri, Elias; Pérez Galán, Patricia; Roué, Gaël; Colomer Pujol, Dolors
1-Jan-2019High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformationCarreras, Joaquim; López Guillermo, Armando; Kikuti, Yara Yukie; Itoh, Johbu; Masashi, Miyaoka; Ikoma, Haruka; Tomita, Sakura; Hiraiwa, Shinichiro; Hamoudi, Rifat; Rosenwald, Andreas; Leich, Ellen; Martínez, Antonio; Roncador, Giovanna; Villamor i Casas, Neus; Colomo Saperas, Lluís; Pérez Galán, Patricia; Tsuji, Noriko M.; Campo Güerri, Elias; Nakamura, Naoya
28-Nov-2016Innovative therapies targeting tumor-microenvironment crosstalk in indolent B-cell non-Hodgkin lymphomasMatas Céspedes, Alba
1-Apr-2019Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphomaRecasens Zorzo, Clara; Cardesa Salzmann, Teresa; Petazzi, Paolo; Ros Blanco, Laia; Esteve Arenys, Anna; Clot, Guillem; Guerrero Hernández, Martina; Rodríguez, Vanina; Soldini, Davide; Valera Barros, Alexandra; Moros Sanz, Alexandra; Climent, Fina; González Barca, Eva; Mercadal, Santiago; Arenillas Rocha, Leonor; Calvo, Xavier; Mate, José L.; Gutiérrez García, Gonzalo; Casanova Rigat, Isolda; Mangues Bafalluy, Ramon; Sanjuan Pla, Alejandra; Bueno, Clara; Menéndez Buján, Pablo; Martínez, Antonio; Colomer Pujol, Dolors; Estrada Tejedor, Roger; Teixidó, Jordi; Campo Güerri, Elias; López Guillermo, Armando; Borrell, José I.; Colomo Saperas, Lluís; Pérez Galán, Patricia; Roué, Gaël
19-Jun-2018Preclinical evaluation of the antitumor activity of a new CXCR4 inhibitor: a novel therapeutic approach in diffuse large B-cell lymphomaRecasens Zorzo, Clara
15-Feb-2014Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphomaMontraveta, Arnau; Xargay i Torrent, Sílvia; López-Guerra, Mónica; Rosich, Laia; Pérez Galán, Patricia; Salaverria Frigola, Itziar; Beà Bobet, Sílvia M.; Kalko, Susana; Frías Sanchez, Mercè de; Campàs, Clara; Roué, Gaël; Colomer Pujol, Dolors
28-Apr-2017Targeting the crosstalk between tumor cells and microenvironment: a new therapeutic approach for the treatment of lymphoid neoplasmsVidal Crespo, Anna
19-Feb-2019Targeting tumor microenvironment crosstalk through GPCR receptors and PI3K pathwayGuerrero Hernández, Martina
Oct-2017The BET bromodomain inhibitor CPI203 improves lenalidomide activity in in vitro and in vivo models of multiple myeloma by synergistic blockade of Ikaros and Myc signaling.Díaz Sánchez, Tania; Rodríguez, Vanina; Lozano, Ester; Mena Jaramillo, Mari Pau; Calderón, Marcos; Rosiñol Dachs, Laura; Martínez, Antonio; Tovar, Natalia; Pérez Galán, Patricia; Bladé, J. (Joan); Roué, Gaël; Fernández de Larrea Rodríguez, Carlos José